Abstract IA-26: Artificial intelligence for regulatory science research

Clicks: 24
ID: 310838
2021
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #7 of 7 articles by views in Clinical Cancer Research

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Artificial Intelligence (AI) has impacted a board range of scientific disciplines that are important to public health, ranging from clinical diagnosis and prognosis, drug and food safety, disease prevention, precision medicine and nutrition. The rise of AI has also offered both opportunities and challenges to regulatory agencies with questions such as (1) how to assess and evaluate AI-based products and (2) how to develop and implement AI-based application to improve the agencies functions. In this presentation, the current thinking and on-going efforts at FDA in the area of AI will be discussed with examples from drug safety and biomarker discovery and development. The guiding principle and best practice of applying AI in regulatory science research will also be discussed with respect to a proposed framework, called TRIAL, for AI transparency, reproducibility, interpretability, applicability and liability. Citation Format: Weida Tong. Artificial intelligence for regulatory science research [abstract]. In: Proceedings of the AACR Virtual Special Conference on Artificial Intelligence, Diagnosis, and Imaging; 2021 Jan 13-14. Philadelphia (PA): AACR; Clin Cancer Res 2021;27(5_Suppl):Abstract nr IA-26.
Reference Key
weida2021abstractiaartificial Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Weida Tong
Journal Clinical Cancer Research
Year 2021
DOI
10.1158/1557-3265.adi21-ia-26
URL
https://aacrjournals.org/clincancerres/article/27/5_Supplement/IA-26/32762/Abstract-IA-26-Artificial-intelligence-for
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.